Excellent point. What do we know about the timing of the enrollment on that trial: are we likely to already have most of the patients enrolled for close to 3 years in order to get clear OS data? Or maybe we should be looking out to the end of this year so did they fill enrollment by the beginning of 2013 or earlier? As I recall, I think that trial started in 2011, is that correct?
Market Data 
Markets 
AI
